Significant Progress Made as Numinus-Sponsored PRIME Study on Psilocybin-Assisted Psychotherapy for Opioid, Stimulant and/or Alcohol Use Disorders Enters Pre-Implementation Stage
Numinus Wellness (OTC:LKYSD) and Syreon Corporation, a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. The study will contribute to a growing body of research to inform larger randomized controlled trials for these indications. The study will take place in Vancouver and will enroll 30 individuals with opioid, stimulant and/or alcohol use disorders. Syreon is leading the trial as Clinical Research Organization (CRO) with Numinus as the trial sponsor.
ТОП-5 лучших рамных внедорожников на вторичке
podrobnosti.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from podrobnosti.ua Daily Mail and Mail on Sunday newspapers.
203 случая заражения коронавирусом подтвердились в Иркутской области за сутки
irk.kp.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from irk.kp.ru Daily Mail and Mail on Sunday newspapers.
Украинский политолог объяснил борьбу Киева с Россией в ЕСПЧ
ura.news - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ura.news Daily Mail and Mail on Sunday newspapers.
В Краснодаре в районе улицы Тихорецкой запретят стоянку транспорта
kuban.kp.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kuban.kp.ru Daily Mail and Mail on Sunday newspapers.